4.7 Article

A water-dependent reversible photoacidity strategy for cancer treatment

期刊

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2022.114669

关键词

Reversible photoacidity; Mechanism; Hydrogen bonds; Water; Cancer

资金

  1. National Natural Science Foundation of China [61575208]
  2. Beijing Institute of Technology Research Fund Program for Young Scholars [1870012222103]
  3. CAMS Innovation Fund for Medical Sciences (CIFMS) [2019-I2M-5-061]

向作者/读者索取更多资源

A water-dependent reversible photoacidity (W-RPA) mechanism has been discovered, in which the proton is dissociated from water locked by a thiadiazoloquinoxaline compound (TQs-Th-PEG5) under laser irradiation. This mechanism has been applied for cancer treatment and shows promising antitumor effects.
In the reported mechanisms of reversible photoacidity, protons were dissociated from compounds which con-tained hydroxyl, indazole or formed hydroxyl via intramolecular hydrogen abstraction under irradiation. Herein, a water-dependent reversible photoacidity (W-RPA) mechanism mediated by a thiadiazoloquinoxaline com-pound (TQs-Th-PEG5) has been found, in which the proton is not dissociated from TQs-Th-PEG5 itself but from a water locked by TQs-Th-PEG5 under the irradiation of a 660 nm laser. After turning off the laser, the produced acid will disappear quickly. This process is repeatable with no consumption of TQs-Th-PEG5. More importantly, water is indispensable. Furthermore, it is confirmed that there is no other element involved in the process except TQs-Th-PEG5, light and water. Excitingly, W-RPA therapy mediated by TQs-Th-PEG5 nanoparticle exhibits remarkable antitumor effect both in vitro and in vivo, especially in hypoxic tumors with diameter larger than 10 mm owing to its oxygen-independent feature. This study not only discovers a W-RPA mechanism but also pro-vides a novel phototherapy strategy for cancer treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据